Pneumococcal conjugate vaccine, 13-valent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pneumococcal conjugate vaccine, 13-valent, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants [Phase 3]